HCA Midwest Division — Kansas City, Missouri

HCA Midwest Division is a clinical research site located in Kansas City, Missouri, United States 64132.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

HCA Midwest Division has participated in 13 clinical trials with 4 currently active.

Therapeutic areas: Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Metastatic Prostate Cancer, Triple-negative Breast Cancer.

Sponsors: Hoffmann-La Roche, Bristol-Myers Squibb, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HCA Midwest Division?

HCA Midwest Division has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HCA Midwest Division conducted?

HCA Midwest Division has 13 clinical trials on record, with 4 currently active. Their work covers Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Metastatic Prostate Cancer, Triple-negative Breast Cancer.

Is HCA Midwest Division accredited by Crixeo Health?

Yes — HCA Midwest Division holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about HCA Midwest Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.